story of the week
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
JAMA 2020 Aug 25;324(8)761-771, NL Pereira, ME Farkouh, D So, R Lennon, N Geller, V Mathew, M Bell, JH Bae, MH Jeong, I Chavez, P Gordon, JD Abbott, C Cagin, L Baudhuin, YP Fu, SG Goodman, A Hasan, E Iturriaga, A Lerman, M Sidhu, JF Tanguay, L Wang, R Weinshilboum, R Welsh, Y Rosenberg, K Bailey, C RihalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.